Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(29%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_3
1
14%
Ph phase_2
3
43%
Ph phase_1
2
29%
Ph phase_4
1
14%

Phase Distribution

2

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(5)

Detailed Status

Completed5
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (28.6%)
Phase 23 (42.9%)
Phase 31 (14.3%)
Phase 41 (14.3%)

Trials by Status

completed571%
active_not_recruiting229%

Recent Activity

2 active trials
Showing 5 of 7
active_not_recruitingphase_2

Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

NCT04350138
completedphase_2

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

NCT05294588
active_not_recruitingphase_1

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

NCT06647407
completedphase_1

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

NCT06128733
completedphase_2

Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination

NCT04722003
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04350138Phase 2

Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

Active Not Recruiting
NCT05294588Phase 2

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

Completed
NCT06647407Phase 1

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Active Not Recruiting
NCT06128733Phase 1

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Completed
NCT04722003Phase 2

Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination

Completed
NCT03632720Phase 3

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom

Completed
NCT04094883Phase 4

Study to Assess Gonorrhoeae Immune Responses Induced by a N. Meningitidis Vaccine

Completed

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7